Opening Bell Analysts Research Calls for Tuesday, February 21
This report was sent to Briefing.com subscribers earlier today. https://briefing.com Research calls posted earlier this morning are available here. Upgrades: > Alliant Energy (LNT) upgraded to Neutral from Sell at Guggenheim; tgt raised to $52 > Glacier Bancorp (GBCI)…
This report was sent to Briefing.com subscribers earlier today. https://briefing.com
Research calls posted earlier this morning are available here.
Upgrades:
> Alliant Energy (LNT) upgraded to Neutral from Sell at Guggenheim; tgt raised to $52
> Glacier Bancorp (GBCI) upgraded to Outperform from Mkt Perform at Raymond James; tgt $51
> HomeTrust Bank (HTBI) upgraded to Buy from Neutral at Janney
> Lakeland Financial (LKFN) upgraded to Outperform from Mkt Perform at Raymond James; tgt $78
> MarineMax (HZO) upgraded to Buy from Neutral at B. Riley Securities; tgt lowered to $52
> Prosperity Bancshares (PB) upgraded to Outperform from Mkt Perform at Raymond James; tgt $85
> Travere Therapeutics (TVTX) upgraded to Outperform from Neutral at Wedbush; tgt $30
> Trustmark (TRMK) upgraded to Outperform from Mkt Perform at Raymond James; tgt $34
Downgrades:
> Actinum Pharma (ATNM) downgraded to Mkt Perform from Outperform at William Blair
> American Equity Investment Life (AEL) downgraded to Neutral from Overweight at Piper Sandler; tgt raised to $48
> Annaly Capital Mgmt (NLY) downgraded to Hold from Buy at Argus
> Axos Financial (AX) downgraded to Outperform from Strong Buy at Raymond James; tgt $55
> Cable ONE (CABO) downgraded to Underweight from Equal Weight at Wells Fargo; tgt lowered to $680
> Claros Mortgage Trust (CMTG) downgraded to Mkt Perform from Mkt Outperform at JMP Securities
> Cullen/Frost (CFR) downgraded to Mkt Perform from Outperform at Raymond James
> First Commonwealth (FCF) downgraded to Mkt Perform from Outperform at Raymond James
> First Merchants (FRME) downgraded to Outperform from Strong Buy at Raymond James; tgt $50
> Focus Financial (FOCS) downgraded to Hold from Buy at Truist; tgt raised to $53
> Generac (GNRC) downgraded to Hold from Buy at Truist; tgt $145
> Kinsale Capital (KNSL) downgraded to Neutral from Buy at Compass Point; tgt $350
> Origin Bancorp (OBNK) downgraded to Outperform from Strong Buy at Raymond James; tgt lowered to $43
> RE/MAX Holdings (RMAX) downgraded to Equal-Weight from Overweight at Stephens; tgt lowered to $21
Others:
> Albemarle (ALB) initiated with a Market Perform at CICC
> Alnylam Pharma (ALNY) initiated with a Buy at EF Hutton; tgt $304
> BioMarin Pharmaceutical (BMRN) initiated with a Neutral at Citigroup; tgt $116
> Oncternal Therapeutics (ONCT) assumed with a Buy at Brookline; tgt $6
> Ryan Specialty Group (RYAN) initiated with an Underperform at Autonomous; tgt $35
> TXO Energy Partners (TXO) initiated with a Strong Buy at Raymond James; tgt $34
> TXO Energy Partners (TXO) initiated with an Overweight at CapitalOne; tgt $35
> Workday (WDAY) named Catalyst Call Buy Idea at Deutsche Bank
Contact [email protected] for any questions or corrections.
Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.
He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.